Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin versus caffeine for post-dural puncture headache after cesarean section
IRCT20210314050703N2Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of gabapentin and caffeine in post-dural puncture headache (PDPH) (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Headache. Started Jun 2021; status: completed.
02
Drugs
gabapentincaffeine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on IRCT20210314050703N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210314050703N2.